Method and reagent for the modulation of female reproductive diseases and conditions
OwnerJennifer Lockridge, Pamela Pavco +1inventors
InventorsJennifer Lockridge, Pamela Pavco, Gilad Gordon
Life of this patent
Estimating the term…
Loading patent…
OwnerJennifer Lockridge, Pamela Pavco +1inventors
InventorsJennifer Lockridge, Pamela Pavco, Gilad Gordon
Estimating the term…
The present invention relates to nucleic acid molecules, including dsRNA, siRNA, antisense, 2,5-A chimeras, aptamers, and enzymatic nucleic acid molecules, such as hammerhead ribozymes, DNAzymes, and allozymes, which modulate the expression of vascular endothelial growth factor receptor (VEGF) and/or vascular endothelial growth factor receptor (VEGFr) genes for the treatment and/or diagnosis of female reproductive disorders and conditions, including but not limited to endometriosis, endometrial carcinoma, gynecologic bleeding disorders, irregular menstrual cycles, ovulation, premenstrual syndrome (PMS), and menopausal dysfunction.
A method for treating endometriosis in a mammalian subject comprising contacting the subject with a nucleic acid molecule that modulates the expression of VEGF, VEGFR1, VEGFR2 or combinations thereof under conditions suitable for said treatment.
A method for treating a endometriosis in a mammalian subject comprising administering to the subject a nucleic acid molecule that modulates the expression of VEGF, VEGFR1, VEGFR2 or combinations thereof under conditions suitable for said treatment
Dependencies are inferred from the claim text.